相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
(S)-Ketoprofen; Dexketoprofen
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
22161-81-5
- 规格:
10 mM * 1 mL/1 g/5 g
| 规格: | 10 mM * 1 mL | 产品价格: | ¥189.0 |
|---|---|---|---|
| 规格: | 1 g | 产品价格: | ¥172.0 |
| 规格: | 5 g | 产品价格: | ¥522.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
S-(+)-Ketoprofen
CAS No. : 22161-81-5
MCE 国际站:S-(+)-Ketoprofen
产品活性:S-(+)-Ketoprofen 是 COX-1 和 COX-2 的有效抑制剂,IC50 值分别为 1.9 和 27 nM。
作用靶点:COX
In Vitro: S-(+)-Ketoprofen (Compound 1) is a potent inhibitor of both COX-1 and COX-2 with IC50s of 1.9 and 27 nM, respectively.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | FDA-Approved Drug Library | CNS-Penetrant Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Pyroptosis Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Pancreatic Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Antidepressant Compound Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Off-patent Drug Library | Highly Selective Inhibitors Library | Acetaminophen | Indomethacin | Celecoxib | EIPA | Aspirin | Oxidopamine hydrobromide | Deferiprone | Diclofenac | Gallic acid | Ibuprofen | Catechin | 20(S)-Ginsenoside Rg3 | Cucurbitacin B | Carprofen | Meloxicam | (-)-Epicatechin | NS-398 | Naproxen | Xanthohumol | Flufenamic acid | Salicylic acid | Phenacetin | Ketoprofen | SC-560 | Rebamipide | Ginsenoside Rd
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验,a = 1.01。随着DDG 的增加,对映体选择性将表现为相应的指数级增长。Pirkle等用实验印证了这种关系[8],在图2所示的CSP上,用30% 异丙醇/正己烷为流动相,N-(3, 5-二硝基苯甲酰基)-亮氨酸正己酰胺的对映异构体选择性测定值a = 10.5,其中(S)-对映体保留较长,相互作用能之差DDG = -5.93 kJ/mol。 同样,对具有两个手性中心如图3所示化合物的(SS), (RR)对映体,可以预料:由于手性中心相隔较远,与CSP作用的自由能之差为2DD Gm ,实验
技术资料暂无技术资料 索取技术资料

















